GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Quest Laboratories Ltd (NSE:QUESTLAB) » Definitions » Return-on-Tangible-Equity

Quest Laboratories (NSE:QUESTLAB) Return-on-Tangible-Equity : 34.19% (As of Mar. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Quest Laboratories Return-on-Tangible-Equity?

Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Quest Laboratories's annualized net income for the quarter that ended in Mar. 2024 was ₹93.8 Mil. Quest Laboratories's average shareholder tangible equity for the quarter that ended in Mar. 2024 was ₹274.3 Mil. Therefore, Quest Laboratories's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2024 was 34.19%.

The historical rank and industry rank for Quest Laboratories's Return-on-Tangible-Equity or its related term are showing as below:

NSE:QUESTLAB's Return-on-Tangible-Equity is not ranked *
in the Drug Manufacturers industry.
Industry Median: 6.67
* Ranked among companies with meaningful Return-on-Tangible-Equity only.

Quest Laboratories Return-on-Tangible-Equity Historical Data

The historical data trend for Quest Laboratories's Return-on-Tangible-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Quest Laboratories Return-on-Tangible-Equity Chart

Quest Laboratories Annual Data
Trend Mar21 Mar22 Mar23 Mar24
Return-on-Tangible-Equity
11.12 51.69 40.21 46.15

Quest Laboratories Quarterly Data
Mar21 Mar22 Mar23 Sep23 Dec23 Mar24
Return-on-Tangible-Equity Get a 7-Day Free Trial - - - 25.18 34.19

Competitive Comparison of Quest Laboratories's Return-on-Tangible-Equity

For the Drug Manufacturers - General subindustry, Quest Laboratories's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Quest Laboratories's Return-on-Tangible-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Quest Laboratories's Return-on-Tangible-Equity distribution charts can be found below:

* The bar in red indicates where Quest Laboratories's Return-on-Tangible-Equity falls into.


;
;

Quest Laboratories Return-on-Tangible-Equity Calculation

Quest Laboratories's annualized Return-on-Tangible-Equity for the fiscal year that ended in Mar. 2024 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(A: Mar. 2024 )  (A: Mar. 2023 )(A: Mar. 2024 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets )/ count )
(A: Mar. 2024 )  (A: Mar. 2023 )(A: Mar. 2024 )
=100.939/( (150.995+286.434 )/ 2 )
=100.939/218.7145
=46.15 %

Quest Laboratories's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2024 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(Q: Mar. 2024 )  (Q: Dec. 2023 )(Q: Mar. 2024 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets)/ count )
(Q: Mar. 2024 )  (Q: Dec. 2023 )(Q: Mar. 2024 )
=93.784/( (262.215+286.434)/ 2 )
=93.784/274.3245
=34.19 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Mar. 2024) net income data. Return-on-Tangible-Equity is displayed in the 10-year financial page.


Quest Laboratories  (NSE:QUESTLAB) Return-on-Tangible-Equity Explanation

Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.


Be Aware

Net Income is used.

Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.


Quest Laboratories Return-on-Tangible-Equity Related Terms

Thank you for viewing the detailed overview of Quest Laboratories's Return-on-Tangible-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Quest Laboratories Business Description

Traded in Other Exchanges
N/A
Address
Plot No. 45, Sector III, Pithampur Industrial Area, District Dhar, Pithampur, MP, IND, 454775
Quest Laboratories Ltd is engaged in the business of manufacturing pharmaceutical formulations across a broad spectrum, including antibiotics, antimalarials, antispasmodics, anti-inflammatories, antiemetics, respiratory medications, diabetes treatments, antidepressants, and more. It produces various products, comprising ethical drugs, generic drugs, and over-the-counter drugs, and is also available in various forms such as tablets, liquid orals, oral dry powders, oral powders (ORS), ointments, and external liquids.

Quest Laboratories Headlines

No Headlines